Dr. Ling Su named new DIA board president
DIA announced the appointment of Dr Ling Su as President of the DIA Board of Directors.
Dr. Su is Senior Vice President and Head of Development Greater China Region of Beijing Novartis Pharma Co., Ltd. He is also an adjunct professor in the School of Pharmacy at Fudan University in Shanghai. Dr. Su brings more than 20 years of experience to DIA, specifically in the areas of regulatory affairs, clinical research and development, R&D strategies, pharmacovigilance, pharmacoepidemiology, and outcomes research.
Dr. Su has served as chair of the DIA Provisional Advisory Council of China and received the DIA Outstanding Service Award in 2000.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.